RECENT NEWS

The UK Sepsis Trust has commissioned and is fully funding a new study, led by the University of St Andrews, which aims to improve sepsis diagnosis and lead to lifesaving interventions.

Swedish firm Inify Laboratories, which offers prostate cancer diagnostics, has chosen Milton Park in Oxfordshire as the site for its first UK laboratory.

Revvity has announced a programme for expansion of its type 1 diabetes (T1D) offering to include a population-scale assay for early detection with support from Sanofi, as well as a new laboratory-developed test to expand clinical testing for early-stage disease screening.

Proscia is introducing virtual staining in its Concentriq software platform to help laboratories reduce the costs associated with traditional chemical methods and drive efficiency in high-throughput workflows.

A pioneering ‘cloud-based’ AI research screening platform, funded by the National Institute for Health and Care Research (NIHR) will enable NHS trusts across the country to join Al trials aiming to help speed up diagnosis.

The Department of Health and Social Care says the NHS will move from a ‘cheapest-first’ to a ‘patient-first’ approach to purchasing medical technology, as it aims to cut waiting lists and save money in the long term.

The Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA), an international organisation that advances the use of validated AI solutions in clinical practice, has announced that Epredia has won three categories in the ISB awards.

Lunit a leading provider of AI for cancer diagnostics and biomarkers for oncology therapeutics, has announced a strategic partnership with CellCarta, a globally recognised provider of CRO laboratory services for pharmaceutical research and development.

Aminur Khan, Country Lead UK and Ireland, Beckman Coulter Diagnostics tells Pathology in Practice about his company's presence at Congress and what to expect in the future.

The NHS should get quicker access to the latest AI tools, thanks to a new National Commission that has been tasked with advising the Medicines and Healthcare products Regulatory Agency (MHRA) on how to re-write the regulatory rulebook on AI in healthcare, which will be published next year.

Leica Biosystems and Florida-based Moffitt Cancer Center, one of the USA’s top cancer hospitals and a leader in cancer research, have announced an expansion of their partnership to accelerate the adoption of digital pathology across the state.

Life sciences firm Promega UK has announced the launch of a new programme of Continuing Professional Development (CPD) courses, designed to support those working in the clinical field of life sciences including biomedical scientists, pathologists, and life-sciences researchers.

IBMS President Joanna Andrew talks to Pathology in Practice at Congress 2025.

Pathology in Practice hears from Jennifer Dougan, National Sales Manager, Bruker and ELITech about the product offering from the two firms, which are exhibiting together at Congress for the first time.

Launch Diagnostics' Chris Waghorn tells Pathology in Practice about his company's presence at Congress this year.

Yannig Querel, Marketing Manager at Stago UK, tells Pathology in Practice about the new Stago sthem0 coagulation analysers, which are on display at Congress.

Una Health's Commercial Director POCT, Naomi Chant tells Pathology in Practice about some of the new products the company is showing at Congress.

Matt Casey, Marketing & Sales Support Manager, Sarstedt tells Pathology in Practice Editor Andy Myall about the firm's stand at Congress 2025.

Pathology in Practice hears from Dan Plews, Senior Business Development Manager, about Source LDPath's presence at Congress.

Pathology in Practice Editor Andy Myall hears what's new at Congress from Pro-Lab Diagnostics, with General Manager and Founder Mark Reed.